MONTREAL, Feb. 28, 2023 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced the signing of an exclusive worldwide license agreement (the “License Agreement”) with the University of Arizona. The License Agreement grants Sunshine Biopharma exclusive […]

BEAVERTON, Ore., February 27, 2023–(BUSINESS WIRE)–WiSA Technologies, Inc. (NASDAQ: WISA), a developer of spatial, wireless sound technology for smart devices and next-generation home entertainment systems, will report its fourth quarter and full year 2022 results on Thursday, March 16, 2023, before market open. Management will hold a conference call to discuss the results and provide a […]

DETROIT, Feb. 27, 2023 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform that delivers 99% learner retention for business and education markets, announces today it will be posting a video shareholder update to its website on Monday, February 27, 2023 at 1:00 PM ET. The presentation […]

LONDON and NEW YORK, Feb. 23, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (LSE: OKYO, NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company developing OK-101 to treat dry eye disease (DED) to address the significant unmet need in this multi-billion-dollar market, today announces the appointment of Jay S. Pepose, M.D., Ph.D., Founder and Medical Director of the […]

SHARON, Penn., February 23, 2023–(BUSINESS WIRE)–Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (“Mawson” or the “Company”), a digital infrastructure provider, announces today that it has closed its facility in Condong, NSW, Australia, with a focus on its operations in the United States exclusively, with all Mawson owned ASIC miners and MDC equipment being transferred to Pennsylvania for […]

TEL AVIV, Israel, Feb. 23, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced it has signed a definitive agreement to sell a 49% interest in its wholly owned subsidiary, SciSparc Nutraceuticals […]

Tel Aviv, Israel, Feb. 22, 2023 (GLOBE NEWSWIRE) — Jeffs’ Brands Ltd (the “Company” or “Jeffs’ Brands”) (Nasdaq: JFBR), a data-driven e-commerce company operating on the Amazon Marketplace, today announced that it has entered into a non-binding letter of Intent (the “LOI”) in order to establish a collaboration with SuperBuzz Inc. (“SuperBuzz”), an artificial intelligence […]

Tel Aviv, Israel, Feb. 22, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced today that as part of its ongoing collaboration with Clearmind Medicine Inc. (Nasdaq: CMND) (CSE: CMND), (FSE: CWY) (“Clearmind”), […]

LONDON and NEW YORK, Feb. 21, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO) (“OKYO”, “OKYO Pharma” or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease to address the significant unmet need in this multi-billion-dollar market, today announced that its CEO, Gary S. Jacob, Ph.D., […]